Article
Human malignant melanoma: detection of BRAF- and c-kit-activating mutations by high-resolution amplicon melting analysis.
Human pathology - 1 May 2005
Willmore-Payne Carlynn, Holden Joseph A, Tripp Sheryl, Layfield Lester J
Abstract excerpt
Activating mutations in the BRAF kinase have been reported in a large number of cases of malignant melanoma. This suggests that therapy with specific RAF kinase inhibitors may find use in treating this disease. If the response to RAF kinase inhibition is dependent on the presence of an activated BRAF protein, it will be necessary to evaluate cases of malignant melanoma for the presence or absence of BRAF...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
